ARTICLE / CLIENT ALERT
CMS Unveils Plans for Long Term Care Facility Infection Control Enforcement Actions
June 5, 2020
Read time: 11 min
Since the early stages of the Coronavirus (COVID-19) pandemic, long term care facilities (LTCFs) have been an epicenter of transmission. Medicare Requirements for Participation for LTCFs include an obligation to establish and maintain an infection control program designed to provide a safe, sanitary and comfortable environment that helps to prevent the development and transmission of communicable diseases and infection (42 CFR § 483.80). For many LTCFs, COVID-19 has made this a difficult requirement with which to comply, given the challenges presented by providing care in an environment that is both residential and clinical, the unique personal care needs of LTCF residents, and limited supplies of personal protective equipment and COVID-19 tests. Press reports have detailed the impact of COVID-19 on LTCFs nationally and internationally.
Routine surveys and inspections of LTCFs and other healthcare facilities were suspended at the height of COVID-19. Now that infection rates have started to decrease nationwide, the Centers for Medicare and Medicaid Services (CMS) has announced new instructions for state survey agencies to more intensively evaluate LTCFs and to cite facilities that fail to follow federal safety requirements. On June 1, 2020, CMS released a Quality, Safety and Oversight Group (QSO) memorandum (QSO 20-31) directing state survey agency directors on a series of new steps that CMS believes will safeguard the health and safety of LTCF residents by addressing infection control deficiencies in these facilities. These steps are to be implemented immediately, will cause a rapid uptick in survey activity and related enforcement effects for LTCFs, and will carry meaningful financial impact for states.
Focused Infection Control Nursing Home Surveys
As we previously reported, since March 4, 2020, state survey agencies have prioritized inspections of healthcare facilities to only the most serious matters. Subsequently, on March 23, 2020, state survey agencies were further instructed to limit their survey activities to just two situations:
- Complaints and facility-reported incidents that were triaged at the Immediate Jeopardy Level
- “Focused Infection Control Surveys” using a streamlined review checklist that focuses on critical elements associated with the transmission of COVID-19, including:
- Overall effectiveness of the LTCF’s infection prevention and control program
- Standard and transmission-based precautions
- Quality of resident care practices, including residents with laboratory-confirmed COVID-19 infections
- The facility’s surveillance plan
- Visitor entry and facility screening practices
- Education, monitoring and screening practices for staff
- Policies and procedures to address staffing issues during emergencies, including COVID-19 transmission.
CMS made the Focused Infection Control Survey checklist available to LTCFs and encouraged them to use it as a self-assessment tool and to discern CMS’s expectations for a thorough COVID-19 infection prevention and control program.
QSO 20-31 reports that as of June 1, 2020, approximately 54% of LTCFs had been subject to Focused Infection Control Surveys, with state averages ranging from 11% to 100% completion. Now that nursing homes are required to submit data to the Centers for Disease Control and Prevention (CDC) regarding instances of COVID-19 in their facilities (as we described here), CMS has articulated a need to prioritize Focused Infection Control Surveys by linking these efforts to receipt of Coronavirus Aid, Relief and Economic Security (CARES) Act funds.
Specifically, through the CARES Act, Congress has appropriated $81 million for state survey agencies to request for use in their survey and certification efforts, in addition to $397 million in previously budgeted funds. For states that have not performed 100% of LTCF Focused Infection Control Surveys in their states by July 31, 2020, CMS will require submission of a corrective action plan outlining the state survey agency’s plans for completion within 30 days. If the survey agency remains noncompliant during this 30-day extension, it may have its allocated 2021 survey funding reduced by up to 10%. For each subsequent 30-day period of noncompliance, CMS may impose further funds withholdings of 5%. In a June 1, 2020, press release announcing the enforcement actions discussed in QSO 20-31, CMS suggests that states that achieve CMS’s goal of 100% completion of Focused Infection Control Surveys in their states by July 31, 2020, will be permitted to request their entire 2020-2023 CARES-Act-related survey funds, and may apply to share in the pool of redistributed funds withheld from state survey agencies that did not achieve CMS’s performance goals.
Although it is yet to be determined whether CMS has the authority to withhold and redistribute apportioned funds in this way, state survey activities likely will increase significantly in June and July rather than risk jeopardizing access to this crucial money, even while many LTCFs are still battling COVID-19.
Additional LTCF Survey Activities
CMS also announced in QSO 20-31 the launch of additional obligatory state survey activities related to LTCFs and COVID-19. Failure to comply with these additional survey obligations may result in a state’s forfeiture of 5% or more of CARES Act survey funds.
- By July 1, 2020, state survey agencies must perform onsite surveys of any LTCF with a previous COVID-19 outbreak. CMS defines an outbreak as (i) total cases in excess of 10% of a LTCF’s total bed capacity, (ii) total cases plus total suspected cases in excess of 20% of a LTCF’s total bed capacity, or (iii) 10 or more reported deaths due to COVID-19. CMS did not specify whether cases involving staff should be included in these counts.
- State survey agencies must perform an onsite survey of any LTCF with three or more new suspected or confirmed COVID-19 cases within three to five days of identifying such cases in the event such cases arose in the time since the facility’s prior National Healthcare Safety Network (NHSN) report submitted to CDC. CMS did not specify whether cases involving staff would trigger a survey.
- Agencies must inspect facilities within three to five days of a confirmed COVID-19 case in a resident if that facility previously reported no COVID-19 cases.
- Beginning in 2021, agencies must perform Focused Infection Control Surveys on 20% of LTCFs in the state using the CMS Focused Infection Control Survey checklist. Facilities may be chosen at the state’s discretion using criteria meant to identify facility and community risk.
CMS is also calling on state survey agencies to return to their pre-COVID-19 survey activities once states have entered the third phase of CMS Nursing Home Reopening Guidance. Once this milestone is reached (or earlier at the state’s discretion), agencies are authorized to resume the following survey activities:
- Non-Immediate Jeopardy complaint investigations
- Revisits of facilities that addressed Immediate Jeopardy complaints but remain out of compliance
- Special Focus Facility and Special Focus Facility Candidate recertification surveys
- Recertification surveys for LTCFs and Intermediate Care Facilities for Individuals with an Intellectual Disability that are greater than 15 months.
CMS expects that surveyors will prioritize inspections based on facilities’ history of noncompliance or allegations of noncompliance involving abuse or neglect, infection control, transfer or discharge violations, insufficiency or incompetency of staff, or other quality of care issues. Accreditation bodies are also authorized to resume normal LTCF survey activities.
Enforcement Actions Against LTCFs Related to Infection Control Survey Deficiencies
CMS considers infection control deficiencies to be an ongoing compliance concern for LTCFs, and COVID-19 has highlighted the importance of compliance with CMS Requirements for Participation for infection control. To that end, QSO 20-31 addresses CMS’s plans to expand its enforcement efforts regarding infection control deficiencies.
In particular, CMS will use the following enforcement remedies if a survey shows an LTCF to be out of compliance:
- Infection control noncompliance with no prior citations during the last year or since the prior standard survey:
- Current non-widespread noncompliance (Level D&E) = Directed Plan of Correction
- Current widespread noncompliance (Level F) = Directed Plan of Correction, discretionary denial of payments for new admissions, 45 days to achieve compliance
- Infection control noncompliance with one prior citation during the last year or since the prior standard survey:
- Current non-widespread noncompliance (Level D&E) = Directed Plan of Correction, discretionary denial of payments for new admissions, 45 days to achieve compliance, civil monetary penalty up to $5,000 per instance
- Current widespread noncompliance (Level F) = Directed Plan of Correction, discretionary denial of payments for new admissions, 45 days to achieve compliance, civil monetary penalty (CMP) up to $10,000 per instance
- Infection control noncompliance with two or more prior citations during the last two years or in the period since the second-to-last prior standard survey:
- Current non-widespread noncompliance (Level D&E) = Directed Plan of Correction, discretionary denial of payments for new admissions, 30 days to achieve compliance, civil monetary penalty up to $15,000 per instance (or a per day CMP that exceeds $15,000 in total)
- Current widespread noncompliance (Level F) = Directed Plan of Correction, discretionary denial of payments for new admissions, 30 days to achieve compliance, CMP up to $20,000 per instance (or a per day CMP that exceeds $20,000 in total)
- Infection control noncompliance at the Harm Level (Levels G, H or I) = Directed Plan of Correction, discretionary denial of payments for new admissions, 30 days to achieve compliance, CMP at the highest non-Immediate Jeopardy level
- Infection control noncompliance at the Immediate Jeopardy Level (Levels J, K or L) = Mandatory temporary manager or termination of Medicare enrollment, Directed Plan of Correction, discretionary denial of payments for new admissions, 15 days to achieve compliance, CMP at the highest Immediate Jeopardy level.
Quality Improvement Organization Support
While CMS is increasing its survey activities, it is also providing resources for LTCFs to prepare for infection control surveys and assist in their efforts to address the COVID-19 crisis. Twelve Quality Improvement Organizations (QIOs) received contracts in 2019 to educate and train LTCFs on infection control, prevention and management. QIOs are not survey agencies; rather, their role is to help LTCFs identify deficiencies, create an action plan, and take specific steps to implement infection control and surveillance programs, including through weekly National Infection Control Training sessions. Going forward, QIOs will be deployed to provide technical assistance to 3,000 low performing nursing homes with a history of infection control challenges. States may also request that QIOs provide technical assistance to LTCFs that experienced a COVID-19 outbreak.
Public Data Posting
LTCFs were required to submit their first COVID-19 incidence data to NHSN by May 31, 2020. CMS’s preliminary analysis of this data indicates that facilities with a one-star CMS quality rating were more likely to have large numbers of COVID-19 cases than facilities with a five-star CMS quality rating. In a June 4, 2020, QSO memorandum (QSO 20-32), CMS notified stakeholders that the data would be populated on the Nursing Home Compare website and at https://data.cms.gov/Covid19-nursing-home-data, on June 4, 2020, and updated on a weekly basis, to allow the public to see how COVID-19 has affected nursing homes by state, number of residents and number of staff. Data will also be searchable by facility name. Data will include each facility’s name, the number of confirmed and suspected COVID-19 cases among residents and staff, the number of resident deaths related to COVID-19, availability of PPE and COVID-19 testing, and potential staffing shortages. Relatedly, in a separate June 4, 2020, QSO memorandum (QSO 20-33), CMS notified stakeholders that it would post results of surveys conducted at LTCFs on or after March 4, 2020, on the Nursing Home Compare website. Data will include a spreadsheet of each health inspection conducted, the facility’s demographic information and any findings or citations associated with the inspection. The website will be updated on a monthly basis.
Effective Dates
CMS states that all policies articulated in QSO 20-31 are immediately effective and will remain in effect until CMS provides public notice that the COVID-19 Public Health Emergency has ceased. We anticipate that the content of QSO 20-31 will eventually be included as part of the interpretive guidance provided to surveyors as part of the Medicare Requirements for Participation. The public data reporting plans articulated in QSO 20-32 and QSO 20-33 are also immediately effective. CMS did not state whether these postings would sunset when the COVID-19 crisis and reporting obligations cease.
Key Takeaways
QSO 20-31 represents an important step in addressing infection control practices at LTCFs, but it likely will be accompanied by material challenges for LTCFs in regions with active COVID-19 transmission. LTCFs may wish to prepare themselves as follows:
- Review QSO 20-31 and become familiar with the new enforcement regime.
- Prepare for heightened governmental scrutiny through numerous intensive surveys, many of which may be repeated.
- Continue to maintain sufficient stores of PPE to provide to onsite inspectors to avoid any outside contamination. Remember that facilities may insist on screening anyone coming onsite and barring entry to anyone exhibiting symptoms.
- Identify any potential citations through the use of the CMS self-assessment checklist. If possible, address those issues, or document any attempts to mitigate such issues and why full resolution was not practicable.
- Contact trade associations and advocacy groups for more information or to articulate any concerns with QSO 20-31. Peers may be similarly situated, and a collective voice may lead CMS to scale back the survey and enforcement timeline until the COVID-19 crisis is better managed.
- Continue to monitor state and industry guidance for information regarding assistance from QIOs.
- Notify public relations teams that self-reported COVID-19 data and results from surveys are now publicly available and inquiries from residents, families, media and other stakeholders may be forthcoming.
Three Takeaways: Tensions in the Renewable Energy and Environmental Markets
ARTICLE
Three Takeaways: Tensions in the Renewable Energy and Environmental Markets
June 5, 2020
Read time: 2 min
McDermott recently hosted Jonathan Burnston, Managing Partner of the energy sector financial services firm Karbone, for a discussion of recent developments affecting environmental, social and governance (ESG) investing, renewable energy and carbon offsets.
Three takeaways from this week’s webinar below:
- Interest in ESG investing is unlikely to fade. ESG indices have performed relatively well in the COVID-19 environment and the concerns that motivate ESG investing are not going away.
- ESG investing is different from reducing emissions or pursuing carbon neutrality. Positive returns from ESG investments do not themselves reduce emissions or mitigate the impacts of climate change.
- Corporate interest in becoming “carbon neutral” is also likely to continue. Due to recent economic disruptions, there may be some delays in achieving some previously announced commitments. However, the pressures and concerns that have motivated the interest in carbon neutrality remain powerful forces.
To begin receiving Energy updates, including invitations to the Renewables Roundtable and Q&A Webinar Series, please click here.

Tax Credits for Carbon Capture—Understanding the IRS’s Proposed Rule
ARTICLE / CLIENT ALERT
Tax Credits for Carbon Capture—Understanding the IRS’s Proposed Rule
June 5, 2020
Read time: 12 min
The Internal Revenue Service (IRS) has released a long-awaited proposed rule to implement section 45Q of the Internal Revenue Code, the statutory provision that creates a tax credit for capturing and sequestering carbon dioxide. The proposed regulations clarify several issues, but invite confusion about others. This On the Subject highlights key features of the proposed regulations.
Background: Tax Code Section 45Q
Section 45Q allows taxpayers to claim a tax credit for each metric ton of “qualified carbon oxide” the taxpayer captures from a “qualified facility” and then either stores or uses in a manner that prevents its release into the atmosphere. What counts as “qualified carbon oxide” depends on the type of “carbon capture equipment” that is used.
For equipment placed in service prior to February 9, 2018, and also for “direct air capture” facilities, the only substance that counts is carbon dioxide—the most ubiquitous greenhouse gas. See, Section 45Q(c)(1)(A) & (C). But for carbon capture equipment placed in service after February 9, 2018, the statute defines “qualified carbon oxide” more broadly; the definition includes carbon dioxide and also any “other carbon oxide.” See, Section 45Q(c)(1)(B).
That broad definition is striking because the term “carbon oxide” is not widely used in US environmental regulations. The term “carbon oxide” does not appear even once in the Clean Air Act’s 562-page greenhouse gas reporting rule. See, 40 C.F.R. Part 98. Further, a Google search for “carbon oxide” likely results in the message “did you mean carbon dioxide?”
The amount of the tax credit authorized by section 45Q varies, depending on two factors: (1) when the facility’s “carbon capture equipment” is placed in service, and (2) what the taxpayer does with the “qualified carbon oxide” after capturing it. For factor two, the statute gives the taxpayer three options: (a) dispose of the qualified carbon oxide in “secure geological storage,” (b) use it as an injectant in enhanced oil recovery operations and then dispose of it in secure geological storage, or (c) “utilization.” The statute defines utilization as: (i) “fixation” through photosynthesis or chemosynthesis, such as by growing algae, (ii) conversion to a material or chemical compound in which the qualified carbon oxide is “securely stored,” or (iii) use as a product in a commercial market “as determined by” the US Secretary of the Treasury.
The statute authorizes the IRS to issue whatever regulations may be necessary to implement section 45Q. It also expressly directs the agency to issue regulations concerning certain specific topics, including rules “for determining adequate security measures” for secure geological storage and rules for recapturing the benefit of any tax credit allowed for qualified carbon oxide that ceases to be captured. The Proposed Regulations, released May 28, 2020, follow guidance released February 19, 2020. That guidance, Notice 2020-12 and Revenue Procedure 2020-12, addressed the begin-construction requirement and partnership allocation rules for the carbon capture credit.
Key Features of the Proposed Regulations
1. Qualified Carbon Oxide
The proposed regulations follow the statutory text in defining “qualified carbon oxide” by reference to the type of carbon capture equipment that is used and when that equipment is placed in service. See, Prop. Reg. § 1.45Q-2(a). For “direct air capture facilities,” the only qualified carbon oxide is carbon dioxide. The same is true for carbon capture equipment placed in service prior to February 9, 2018. However, for every other type of carbon capture equipment, the tax credit is available for “any carbon dioxide or other carbon oxide.”
The regulations do not define “other carbon oxide,” and the regulatory preamble indicates that the IRS and the US Department of the Treasury consider the statutory definition of “qualified carbon oxide” to be “clear” and subject to “broad acceptance and use” by “industry participants, environmental groups, and stakeholders.” In fact, however, the term “carbon oxide” is not widely used in the US greenhouse gas regulatory regime. The US Environmental Protection Agency (EPA) has used the term in fewer than 10 notices published in the Federal Register; it has used the term “carbon dioxide” in more than 1,200.
2. Secure Geological Storage
Like the statute, the proposed regulations contemplate a tax credit for “qualified carbon oxide” that is captured and disposed of in “secure geological storage.” See, Prop. Reg. § 1.45Q-3(a). The proposed regulations provide some clarity about what counts as “secure geological storage,” but may also generate confusion unless the IRS provides further clarification:
- Prop. Reg. § 1.45Q-3(a) provides that “secure geological storage” includes, but is not limited to, storage at deep saline formations, oil and gas reservoirs and unminable coal seams.
- Prop. Reg. § 1.45Q-3(b), in turn, provides that a taxpayer will be deemed to have complied with the secure geological storage requirement in three specific situations. Those situations are where the “qualified carbon oxide” is: (1) stored in compliance with Subpart RR of the Clean Air Act’s greenhouse gas reporting rule; (2) used as an injectant in enhanced oil recovery operations and then stored either in compliance with Subpart RR or in compliance with alternative standards endorsed by the American National Standards Institute (ANSI); (3) injected into a well that complies with federal Underground Injection Control regulations.
Critically, the proposed regulations do not use the word “and” or “or” between situations (2) and (3). That invites confusion about whether clause (3) applies in addition to clauses (1) and (2), or as an alternative to them. To be sure, the regulatory preamble suggests that clause (3) applies to a specific type of storage activity (storage in an underground injection well) and that taxpayers using such wells must also comply with either clause (1) or clause (2). But the point would be clearer if it were made in the regulatory text itself, not merely in the preamble.
The proposed regulations also beg the question of whether the three listed situations are the only situations where a taxpayer will have been deemed to comply with the secure geological storage requirement, or if there might be other unlisted situations that are also compliant.
Finally, neither Subpart RR nor the alternative ANSI standard mention the term “carbon oxide.” Both documents repeatedly use the term “carbon dioxide” and appear to be limited to that substance. By citing Subpart RR and the ANSI standard, the proposed regulations provide a compliance pathway for taxpayers that are sequestering “carbon dioxide.” However, it is not at all clear that the regulations provide a compliance pathway for taxpayers sequestering any other substance.
3. Utilization and the Life Cycle Analysis Requirement
Taxpayers that capture “qualified carbon oxide” do not have to use the “secure geological storage” approach to qualify for a tax credit. Taxpayers can also obtain a tax credit by “utilizing” the captured qualified carbon oxide in the manner allowed by section 45Q. That is, they can claim a tax credit if they capture carbon and then use that qualified carbon oxide by growing algae, converting it into a form that is “securely stored” or using it for any other purpose for which a commercial market exists—as determined by the IRS. But how can taxpayers calculate the amount of the tax credit for such utilization? And what commercial markets does the IRS recognize?
The proposed regulations leave those questions largely unanswered. With respect to the tax credit amount, the statute provides that the amount of the credit must be based on “an analysis of lifecycle greenhouse gas emissions.” The proposed regulations, in turn, provide that taxpayers must provide a written life cycle analysis report to the IRS and the US Department of Energy, and that the IRS “will determine whether to approve” that analysis. See, Prop. Reg. § 1.45Q-4(c)(3). The implication is that if the IRS rejects the taxpayer’s analysis, the tax credit will not be available. But the proposed regulation does not in fact say that in express terms. Nor does the proposed regulation explain how long the IRS will take to approve or reject the taxpayer’s analysis or what standards the IRS will use in conducting its review. Perhaps the IRS’s approach would be to use something similar to the private letter ruling process, effectively ruling on the eligibility for the project or process for section 45Q purposes. The proposed regulation is also silent as to which commercial markets qualify.
4. Recapture
The proposed regulations provide a framework for how and when the tax credit is recaptured if qualified carbon oxide leaks during the recapture period. Without this recapture guidance, taxpayers would likely not make the capital investments that this program was intended to incentivize. For this purpose, qualified carbon oxide ceases to be captured, disposed of or used as a tertiary injectant if the leaked amount of qualified carbon oxide in the taxable year exceeds the amount disposed of in secure geological storage or used as a tertiary injectant in the same taxable year. After a leak is discovered, the quantity of the leak under the applicable environmental regulations must be certified by an independent engineer or geologist. The recapture amount is equal to the product of the quantity of recaptured qualified carbon oxide (in metric tons) and the appropriate statutory credit rate.
The recapture period begins on the date of first injection for disposal and ends on the earlier of (i) five years after the last taxable year in which the taxpayer claimed a section 45Q credit or (ii) the date monitoring ends in accordance with the environmental regulatory requirements under Subpart RR or ANSI described above. The length of time for which monitoring is required under the environmental standards depends in large part on how long the specific CO2 injection well used by the taxpayer remains in operation. That period could be more or less than five years, depending on the specific well.
The proposed regulations provide a mechanism for taxpayers to take the recapture of the credit into account in the taxable year in which the leak is identified and reported rather than amending an earlier return in which a credit was taken. The recapture is taken into account and calculated on a last-in, first-out (LIFO) basis, such that the leaked amount that exceeds the amount of qualified carbon oxide disposed of in the current taxable year will be deemed attributable first to the prior taxable year, then to the taxable year before that, up to a maximum of the fifth preceding year.
The proposed regulations provide an exception to credit recapture if the loss of containment is triggered by volcanic activity, a terrorist attack or other events unrelated to the selection, operation or maintenance of the storage facility.
5. Contractual Arrangements for Carbon Sequestration
A taxpayer may claim the section 45Q credit if the taxpayer contracts with a third party to carry out the sequestration, provided the arrangement meets certain requirements. See, Prop. Reg. § 1.45Q-1(h)(2). The taxpayer must contractually ensure in a binding written contract that another party will physically carry out the disposal, injection or utilization of the qualified carbon oxide in accordance with the proposed regulations. To satisfy the binding written contract requirement, the contract must be enforceable under state law and must not limit damages to a specified amount. The contract must require commercially reasonable terms and require that the party physically carrying out the qualifying activity satisfies the regulatory requirements to be eligible for the section 45Q credit pursuant to Prop. Reg. § 1.45Q-(3) and -(4). Further, the contract must require the contracting party to report and provide all necessary information about a recapture event.
The proposed regulations allow flexibility for a taxpayer to enter into multiple contracts with multiple parties for the disposal, injection or utilization of the qualified carbon oxide. The existence of each contract and the parties involved must be reported to the IRS on an annual basis on Form 8933, Carbon Oxide Sequestration Credit, by each party to the contract.
If the taxpayer contracts with a third party to dispose of qualified carbon oxide, utilize qualified carbon oxide or use qualified carbon oxide as a tertiary injectant, the taxpayer additionally may elect to allow such third party to claim the associated section 45Q credit. See, Prop. Reg. § 1.45Q-1(h)(3). The electing taxpayer may not claim any section 45Q credits that are allowable to a credit claimant and may elect to allow a credit claimant to claim the full amount or a partial amount of section 45Q credits arising during the taxable year. An electing taxpayer may elect to allow a single credit claimant or multiple credit claimants to claim section 45Q credits in the same taxable year. If an electing taxpayer allows multiple credit claimants to claim section 45Q credits, the maximum amount of section 45Q credits allowable to each credit claimant is proportional to the amount of qualified carbon oxide disposed of, utilized, or used as a tertiary injectant by the credit claimant. Similarly, in the event of a credit recapture due to leaked qualified carbon oxide, the recapture amount must be allocated on a pro rata basis among the taxpayers who claimed the section 45Q credit. A credit claimant may receive allowances of section 45Q credits from multiple electing taxpayers in the same taxable year.
The election must generally be made no later than the time prescribed by law (including extensions) for filing the federal income tax return or Form 1065 for the year in which the credit arises. The election generally may not be filed with an amended federal income tax return for tax years beginning after the issuance of the proposed regulations. Taxpayers may file an amended return, subject to certain limitations, to make the election for any taxable year ending after February 9, 2018 and beginning before the issuance of the proposed regulations.
6. Public Comments
Interested stakeholders can participate in the IRS’s rulemaking by submitting comments on the proposed regulations. Comments are due on August 3, 2020.
Please note: Unless otherwise indicated, all “section” references are to the Internal Revenue Code of 1986, as amended (the “Code“), all references to “Treas. Reg. §” are to the Treasury Regulations (the “Treasury Regulations”) promulgated thereunder, and all references to “Prop. Reg. §” are to the Proposed Treasury Regulations promulgated thereunder.

Update: Employer Considerations for Returning to the Workplace
ARTICLE / CLIENT ALERT
Update: Employer Considerations for Returning to the Workplace
June 5, 2020
Read time: 14 min
As a follow-up to our recent Alert “Back to the Future: Employer Considerations for Returning to the Workplace,” we are sharing updated advisories recently issued by New York State and the Centers for Disease Control and Prevention (“CDC”), offering guidance on safely reopening offices. The CDC’s most recent guidance updates and supplements its previous guidance on reopening office workplaces. Below we describe some of the key provisions in the state’s guidance.
New York State Updated Interim Guidance for Office-Based Work During the COVID-19 Public Health Emergency
On May 28, 2020, the New York State Department of Health (“DOH”) issued updated “interim guidance” for “all office-based work,” including for both essential and nonessential businesses (“NYS Guidance”). The NYS Guidance provides mandatory requirements for employers and businesses that operate within an “office setting,” including, but not limited to, professional services, nonprofit, technology, administrative support and higher education administration.[1] The NYS Guidance includes many of the suggestions described in our recent Alert. The NYS Guidance reiterates that employers must follow all New York State standards and all applicable federal requirements, such as those promulgated by the CDC and the Occupational Safety and Health Administration (“OSHA”). The owner/operator of the business and the building owner with respect to common areas are responsible for ensuring compliance with these minimum requirements (“Responsible Parties”). While the NYS Guidance applies to regions of the state that are in “Phase Two” of the state’s reopening plan and is based on current health practices for businesses in “Phase Two,” New York City will not enter “Phase One” until June 8, 2020. Because there must be at least two weeks in between phases, New York City may not enter “Phase Two” until at least June 22, 2020.
The NYS Guidance is organized around three categories — People, Places and Processes. With respect to People, the NYS guidance requires the below, among other measures detailed in the updated guidance:
- Social distancing of at least six feet must be maintained among individuals at all times, unless safety of the core activity requires a shorter distance.
- Exception When, for business purposes, individuals must come within six feet of one another, each individual must don an acceptable face covering[2] that covers both their mouth and nose.
- At no point may the total number of individuals in an area exceed 50% of such area’s maximum occupancy limit as set by its certificate of occupancy.
- To maintain adequate social distancing, Responsible Parties may modify or reconfigure their workplaces, limit use of shared work stations, consider closing common seating areas (including reception) and may also install physical barriers in accordance with OSHA’s guidelines.
- Responsible Parties must post signs throughout the workplace to remind employees to, among other items, follow hygiene, cleaning and disinfection protocols.
- The use of small spaces, including elevators, supply rooms and personal offices, must be limited to one person at a time, unless all individuals in such space are wearing acceptable face coverings.
- Employers must limit in-person gatherings to the greatest extent possible.
- When absolutely necessary, in-person meetings should be held in open, well-ventilated spaces with adequate social distancing and with all attendees wearing acceptable face coverings.
- Nonessential common areas, such as gyms, pools and game rooms, must remain closed.
- Other common areas, such as copy rooms, kitchens and reception desks, may remain open provided that adequate social distancing, including reducing bidirectional foot traffic and posting signage and distance markers, is implemented.
- Employers should create policies which encourage employees to successfully work from home when feasible.
- All nonessential travel should be limited.
- Employers must take measures to reduce interactions and contact among individuals in an office, including by staggering work schedules, reducing in-office workforce, reducing bidirectional foot traffic and shifting and/or altering workspaces.
- Responsible Parties should limit on-site interactions and movements to limit contact to the extent possible, including by establishing designated areas for pickups and deliveries.
With respect to Places, the NYS guidance requires the below, among other measures detailed in the updated guidance:
- Employers must provide all necessary PPE as required for its workplace activities, including appropriate face coverings for their employees, at no cost to the employees.
- Employers must train employees on appropriate donning, doffing, cleaning and discarding of PPE, including that face coverings must be cleaned or replaced after each use and may not be shared.
- Responsible Parties must adopt measures to restrict the sharing of objects, such as laptops and office tools, or require employees to perform hand hygiene before and after every contact.
- Responsible Parties must adhere to the DOH’s and the CDC’s hygiene, cleaning, air circulation and disinfection requirements.
- Employers must conduct regular cleaning and disinfection of the office.
- If an employee is suspected or confirmed to have COVID-19, Responsible Parties must, following CDC guidelines, close off, and following 24 hours, if feasible, clean and disinfect areas used by the affected employee, including shared building spaces and restrooms.
- Further, air circulation should be increased in the affected area by opening outside doors and windows.
- Once the affected area has been appropriately cleaned and disinfected, it may be reopened for use.
With respect to Processes, the NYS guidance requires the below, among other measures detailed in the updated guidance:
- Responsible Parties must implement mandatory daily health screenings of their employees and, where practicable, visitors.
- Screenings may be done remotely (e.g., by telephone or online survey) by employees or visitors before arriving at the office.
- Screenings must use a questionnaire that determines whether the individual has:
- Knowingly been in close or proximate contact in the past 14 days with anyone who has tested positive for COVID-19 or who has or had symptoms of COVID-19;
- Tested positive for COVID-19 in the past 14 days; and/or
- Has experienced any symptoms of COVID-19 in the past 14 days.
- An individual that answers any of the above screening questions in the affirmative must not be allowed to enter the office and should be sent home with instructions to contact their healthcare provider and/or self-quarantine for at least 14 days.
- Screening should be coordinated to prevent employees or visitors from intermingling and permit for adequate social distancing while employees and visitors queue for onsite screenings and/or building entry.
- Personnel performing screening activities must be provided with necessary PPE and be appropriately protected from exposure.
- Personnel performing screening activities should be trained on CDC, DOH and OSHA protocols.
- In addition to screenings, daily temperature checks may be conducted.
- Contactless thermal cameras in building entrances may be used to identify symptomatic visitors.
- Employers must review all employee and visitor responses collected by the screening process.
- Employers must further designate a site safety monitor who is responsible for continuous compliance with all aspects of the employer’s site safety plan.
- Employees that have either tested positive for COVID-19, exhibit symptoms of COVID-19 or have had close contact with a person with COVID-19 must complete a 14-day quarantine before returning to work.
- Responsible Parties must notify their local health department and the DOH immediately upon being informed of any positive COVID-19 test result by an employee in their office.
- Employers must immediately notify building managers of any employees showing symptoms of COVID-19 that have entered the workplace.
- Employers must conspicuously post completed safety plans on site.
More guidance may be issued as the pandemic evolves and as more offices reopen and best practices are developed based on region. Employers should continue to monitor, and comply with, local, state and federal guidelines for reopening their workplaces.
Authored by Mark E. Brossman, Ronald E. Richman, Max Garfield and Abdulrahman Alwattar.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
[1] By its own terms, the NYS Guidance does not address medical offices, including doctors’ offices or dentists’ offices, or building owners/managers and their employees or contractors.
[2] Appropriate face coverings include, but are not limited to, cloth-based face coverings and disposable masks that cover both the mouth and nose.
This is a fast-moving topic and the information contained in this Alert is current as of the date it was published.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.
Beware Fraud And Abuse Pitfalls In Precision Medicine
ARTICLE
Beware Fraud And Abuse Pitfalls In Precision Medicine
June 4, 2020
Read time: 1 min
CA SB 977 Would Expand AG Review of Healthcare Transactions
ARTICLE / CLIENT ALERT
CA SB 977 Would Expand AG Review of Healthcare Transactions
June 4, 2020
Read time: 5 min
California Senate Bill (SB) 977, if passed, would broaden the type of healthcare transactions that require California Attorney General (AG) review and approval. SB 977 would require that a healthcare system, private equity group or hedge fund provide written notice to, and obtain the written consent of, the AG prior to any acquisition of or affiliation with a healthcare facility or provider.
The bill defines a healthcare system as an entity that includes or owns two or more hospitals in multiple counties or three or more hospitals in one county. Acquisitions include direct or indirect purchases of any manner, including but not limited to leases, transfers (including but not limited to, any arrangement, written or oral, that alters voting control of, responsibility for, or control of the governing body of the provider), exchanges, options, receipt of conveyances, creation of joint ventures, or any other manner of purchase of all, or any part of, the assets of a healthcare facility or provider by a healthcare system, private equity group or hedge fund. The bill defines an affiliation as an agreement, association, partnership, joint venture or other arrangement in which a healthcare system 1) shares control over healthcare services provided by such a facility or provider, or 2) acquires direct or indirect control over the operations of a healthcare facility or provider, in whole or in substantial part.
Standards for Transaction Approval by AG
Unless the acquisition or affiliation at issue will result in a substantial likelihood of clinical integration (defined as a reduction in costs for the benefit of consumer care and outcomes, or an increase or improvement in the quality of care), a substantial likelihood of increased availability and access to services in an underserved population, or both, the AG must deny consent to the transaction. The AG may also deny consent to a transaction if there is a substantial likelihood of anticompetitive effects (such as raising market prices, diminishing quality or reducing choice) that outweigh the benefits of clinical integration or increased services to underserved populations. This type of analysis requires the transactions to be reviewed by the antitrust division of the AG’s office, rather than by the charitable trusts division. Waivers are available for certain transactions involving healthcare systems in rural areas.
The AG has 60 days from the receipt of written notice to clear the transaction, grant the waiver or request additional information. If additional information is requested, the AG then has 45 days to grant or deny consent to the transaction. The review period may also be extended if the AG decides to a hold a public meeting regarding the transaction, or if the parties substantially modify the acquisition or affiliation. If the AG denies consent to a transaction, any of the parties may appeal the denial by a writ of mandate to the superior court.
Additional Grounds for AG Actions
This bill would make it unlawful for a healthcare system to have substantial market power and act in a way that has a substantial tendency to cause anticompetitive effects (such as raising market prices, diminishing quality, reducing choice or increasing costs). A healthcare system will also be presumed to be acting unlawfully if it has substantial market power and its conduct involves tying or exclusive dealing. A healthcare system’s substantial market power can be shown by 1) conduct that has an actual substantial anticompetitive effect, or 2) a sufficiently substantial market share in one or more markets for any service in trade or commerce (presumed if a healthcare system’s market share is greater than 60%). Civil fines imposed for such violations may be calculated as either $1 million, or as twice the gross gain to the healthcare system or gross loss to any other party multiplied by two, whichever is greater.
Bill Support/Opposition and Progress
SB 977 is supported by AG Xavier Becerra and California labor unions, and is opposed by the California Chamber of Commerce, the United Hospital Association, the California Hospital Association, the California Medical Association, Sutter Health and Tenet Health. On May 13, 2020, the bill passed 7–2 in the California Senate Health Committee. Next, it will be voted upon in the Appropriations Committee and then the Senate generally. If the bill passes both, it will go to the California Assembly and then to the governor.
Conclusion
This legislation would create burdensome and unnecessary processes of review for healthcare transactions while giving the AG arbitrary and absolute discretion to determine when the relevant criteria are met, without clear parameters. Any fees and fines obtained through civil actions will be deposited in the AG’s antitrust account within the general fund, possibly incentivizing the AG to bring such civil suits against healthcare systems. Additionally, while it is early in the process, the relative ease with which the bill passed the Health Committee, the support of the AG, similar bills in other states that have gained traction, and a general desire by many to keep the healthcare market fair and competitive, particularly during uncertain times, suggest there may be an actual chance that the bill will be passed in both houses and approved or signed by the governor.

Contact Tracing Applications: Privacy and Other Legal Considerations for Employers Under Existing Laws and Recent Senate Proposals (COVID-19)
ARTICLE / CLIENT ALERT
Contact Tracing Applications: Privacy and Other Legal Considerations for Employers Under Existing Laws and Recent Senate Proposals (COVID-19)
June 4, 2020
Read time: 14 min
As states have started to reopen their economies amidst the COVID-19 pandemic, employers are evaluating strategies that will allow their employees to return to work while protecting against a resurgence. Among those strategies is the use of technologies that track the movement of individuals for purposes of limiting the spread of COVID-19, in particular contact tracing applications.
The deployment of contact tracing applications by employers raises serious concerns about privacy rights, data security and other workplace legal protections. In response to these concerns, senators have introduced three bills aimed at protecting the privacy of individuals who use contact tracing applications or are subject to other COVID-19-related measures. On May 7, 2020, Republican Senators Roger Wicker, John Thune, Jerry Moran and Marsha Blackburn introduced the COVID-19 Consumer Data Protection Act of 2020 (“Wicker Bill”). On May 14, 2020, Democratic Senators Richard Blumenthal and Mark Warner introduced the Public Health Emergency Privacy Act (“Blumenthal Bill”). Finally, this week, on June 1, 2020, Democratic Senators Maria Cantwell and Amy Klobuchar and Republican Senator Bill Cassidy introduced the Exposure Notification Privacy Act (“Cantwell Bill” and collectively, the “Bills”). While all three Bills aim to protect the privacy of individuals during the nation’s response to the COVID-19 pandemic, the scope, focus and rights provided by each have significant differences.
This Alert provides a brief background on contact tracing applications, a high-level overview of the requirements of the Bills, and a discussion of certain legal issues employers should bear in mind in evaluating the proper role of contact tracing applications in their reopening strategies.
Contact Tracing Applications
Contact tracing applications are smartphone-based applications that track users’ interactions with other users to identify and notify potential exposed contacts.[1] While the design of these applications varies and is quickly evolving, most applications employ a smartphone’s GPS or Bluetooth technology to track users’ interactions. By tracking the whereabouts of users’ devices and their proximity to each other, the contact tracing application is able to notify users of potential exposure to any other users who have self-reported as testing positive for COVID-19. Users who have been exposed might then be advised to contact their local health department to obtain guidance and resources, including the most current recommendations for assessing symptoms and preventing community spread.
While applications have been launched in Europe, Asia and Australia, it remains unclear exactly how contact tracing applications will work, and the extent to which they will be adopted, in the United States.[2] Programs may have differing accessibility for governments and employers and different structures for data centralization. One potential technology for use in the United States, which has received significant media coverage, is the technology under development through a partnership between Apple and Google.[3] An application using a version of this technology, launched in Switzerland on May 26, 2020,[4] follows an opt-in approach (where users voluntarily download and use the application) and uses Bluetooth technology to track users’ interactions in order to identify exposure to COVID-19. The data is stored on individuals’ devices and shared directly with public health authorities only; Apple and Google have said they would not have access to the information collected. Employers also would not have access to this information.
The Senate Bills
Who and What Data Do the Bills Cover?
The Bills aim to protect the privacy of Americans during the COVID-19 public health emergency, focusing on information collected by contact tracing applications. The Bills would regulate certain entities that collect or use personal health information, geolocation data, proximity data and other information generally used by contact tracing applications to track the spread of COVID-19. The most recent bill, the bipartisan Cantwell Bill, specifically targets services associated with the use of contact tracing applications and similar technologies used for the purpose of digitally notifying, in an automated manner, individuals who may have become exposed to an infectious disease.
What Do the Bills Require?
While the Wicker Bill, Blumenthal Bill and Cantwell Bill each have some distinct requirements, the Bills all generally require that regulated entities:
- Minimize the protected information collected to what is needed and take steps to protect the security of protected information;
- Obtain affirmative express consent from individuals to collect or use their protected information;
- Allow individuals to opt out of the collection of their protected information and/or revoke consent;
- Publish a privacy policy, disclosed to consumers prior to or at the point of data collection, that includes how their information will be handled and how long it will be retained; and
- Delete all personally identifiable information upon the user’s request and when it is no longer being used for the public health emergency.
Notably, the Cantwell Bill, unlike the other Bills, would mandate that operators of contact tracing applications and similar technologies collaborate with a public health authority in the operation of such service. Another notable difference in the Cantwell Bill is its restriction against the use of aggregate data for any purpose other than for public health purposes. The Blumenthal Bill and Cantwell Bill would not place any restrictions on the use of aggregate data. Further, the Cantwell Bill, unlike the other Bills, would prohibit discrimination regarding access to public accommodations on the basis of an individual’s choice to use or not use a contact tracing application.[5]
Employer Considerations
If any of these Bills were to pass, they may or may not create direct obligations for employers. For example:
- The Wicker Bill notably excludes from coverage employee screening data, defined as data collected, processed or transferred for the purposes of determining whether the individual is permitted to enter the employers’ physical site of operation. The Wicker Bill would apply only to employers who collect, process or transfer protected information for a purpose that goes beyond employee screening.
- The Blumenthal Bill would apply more generally to organizations collecting, using or disclosing covered information and would not exempt employee screening data. Therefore, its requirements may apply directly to employers.
- More so than the other Bills, the Cantwell Bill targets the providers and notification services associated with the use of contact tracing applications and similar technologies. As such, the Cantwell Bill would also not apply to employers directly.
Whether or not any of these Bills moves forward, employers that are deciding whether to require (or encourage) employees to use contact tracing applications as a way to protect the workplace will need to consider the existing laws that may apply. While not an exhaustive discussion of all issues that may apply to contact tracing applications in the workplace, below is a discussion of some workplace protection, privacy and data security laws to consider.
Workplace Protections
Employers have a duty under the Occupational Safety and Health Act (“OSHA”) to provide their employees with “a place of employment which [is] free from recognized hazards that are causing or likely to cause death or serious physical harm.”[6] The U.S. Equal Employment Opportunity Commission (“EEOC”) has issued guidance concerning workplace protections related to the COVID-19 pandemic, including related to the monitoring of COVID-19 symptoms and making medical inquiries that may impact employers’ use of contact tracing applications. As employers consider requiring or encouraging use of contact tracing applications, the limitations and employee protections imposed by various workplace laws will need to be considered. Striking a balance between protecting employees from exposure to COVID-19 and complying with other workplace rights and protections may prove to be delicate.
For example, under the Americans with Disabilities Act (“ADA”), employers may restrict employee access to the workplace, in a manner no more intrusive than necessary, where there is a “direct threat” to the health and safety of others. COVID-19 has been categorized by the EEOC as a “direct threat,”[7] which means that employers may exclude individuals with COVID-19 from the workplace if the threat posed by the employee cannot be eliminated or reduced by reasonable accommodation. Contact tracing applications have not been suggested as a reasonable accommodation, but arguably could be used as an inquiry to identify the existence of a direct threat to the workplace. Inquiries must be “job-related” and a “business necessity” to be permitted.[8] Permitted inquiries include employee body temperatures and other COVID-19 tests. Contact tracing applications may not, however, qualify as a business necessity, particularly because of the invasiveness of the location tracking in some of these applications and in cases where employees can and do work remotely. If they do qualify, any inquiries conducted must be administered in a non-discriminatory manner. Further, under the ADA, any records of health or medical data collected by employers through inquiries, including contact tracing applications, must be kept separately from the employees’ personnel file.
Restrictions on employee workplace access may also implicate off-duty conduct laws, like those in New York and California, which prohibit employers from discriminating or taking adverse action against their employees for legal activities outside of work.
Employers may also be limited in their ability to require employees to use contact tracing applications based on the device ownership. While employers likely can mandate an employee use a contact tracing application on an employer-owned device, they may not be able to mandate use on employee-owned devices, including those used for Bring Your Own Device (“BYOD”) programs. Employers should review their internal BYOD policies and ensure any contact tracing applications comply with these policies.
Privacy Laws
Existing privacy laws may also impact employers’ adoption of contact tracing applications. For example, if an employer were to require employees to use a contact tracing application, and the data collected by the applications would be shared with the employer, the employer would need to comply with applicable state and federal laws that apply to the types of employee data collected. Many states, including Maine and California, have recently expanded their laws to expressly protect geolocation data as a form of personal information. Further, like the Bills, the California Consumer Privacy Act, which went into effect on Jan. 1, 2020, imposes robust disclosure, opt-out and deletion obligations on entities collecting personal information of this nature. A way to avoid such obligations could be to choose an application design where the employer does not have any access to the data collected, or only has access to anonymized data, and the public health authority and/or vendor engages in all communications with users.
While HIPAA does not apply to most employers,[9] all employers should be aware of communications to and from any contact tracing application they utilize, especially between applications and health plans or health care providers, to ensure that the technology complies with HIPAA. Employers should review contact tracing vendors’ privacy policies to ensure they are HIPAA compliant.[10]
Data Security Laws
Employers who maintain or have access to data collected by contact tracing applications may also be subject to the increasing data security regulation at the state level. For example, under New York’s Stop Hacks and Improve Electronic Data Security Act (“SHIELD Act”), as of March 21, 2020, many companies[11] who possess personal information about New York residents are required to develop, implement and maintain “reasonable safeguards” to protect the “security, confidentiality and integrity” of the collected data. Employers will also need to be sure to comply with state data breach notification laws if there is a security incident involving personal information collected from contact tracing applications.
Other Considerations
An employer’s use of contact tracing applications may trigger other important considerations. For example, an employer should ensure that the new technologies and the collection of personal data comply with its internal data security and privacy policies. Similarly, if an employer is engaging third-party vendors to provide contact tracing applications, the selection and engagement of those vendors should comply with the employer’s vendor policies, particularly if the new technology vendors will also have access to or store any protected information. That would include rigorous vetting of the vendor’s privacy and data security policies.
Conclusion
It is unclear at this point whether any of the Bills will gain momentum and move forward in Congress. Given the significant privacy concerns, contact tracing applications and similar technologies may in fact prove to be fertile ground for the first federal privacy legislation in more than a decade. Regardless, the appropriate role of contact tracing applications is an issue many employers will need to confront as businesses reopen. In deploying any sort of application, employers will need to understand the technology’s design and be cognizant of the privacy, data security and workplace protection laws that such designs implicate. The potential benefits of the applications in terms of safety and preventing workplace spread will need to be carefully weighed against the risks these laws present. Employers will also want to reassess the available designs and the steps taken to comply with such laws on a periodic basis given the high potential for changes in the technological and legal landscapes.
Authored by Edward H. Sadtler, John C. Garces and Melissa J. Sandak.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
[1] Contact tracing applications are intended to supplement manual contact tracing efforts already conducted by public health authorities.
[2] A few states, including North Dakota, South Dakota and Utah, have already launched voluntary contact tracing applications, but adoption rates have been very low. See Elliot Setzer, “Contact Tracing Apps in the United States,” Lawfare, May 6, 2020, available here. Applications in the United States may also be very different from those currently in use in Europe, Asia and Australia. See Miles Johnson et al., “Europe Split Over Approach to Virus Contact Tracing Apps,” Financial Times, May 1, 2020, available here; Yasheng Huang et al., “How Digital Contact Tracing Slowed Covid-19 in East Asia,” Harvard Business Review , April 15, 2020, available here; Josh Taylor, “Covidsafe App: How Australia’s Coronavirus Contact Tracing App Works, What it Does, Downloads and Problems,” The Guardian, May 14 2020, available here.
[3] “Privacy Preserving Contact Tracing,” Apple, available here.
[4] Leo Kelion, “Coronavirus: First Google/Apple-Based Contact-Tracing App Launched,” BBC News, May 26, 2020, available here.
[5] In doing so, the Cantwell Bill potentially restricts the use of contact tracing applications by a broad range of business and other organizations, such as hotels, restaurants and schools. Specifically, the Bill makes it unlawful for “any person or entity to segregate, discriminate against, or otherwise make unavailable to an individual or class of individuals the goods, services, facilities, privileges, advantages, or accommodations of any place of public accommodation (as such term is defined in section 301 of the Americans With Disabilities Act of 1990 (42 U.S.C. 12181)), based on covered data collected or processed through an automated exposure notification service or an individual’s choice to use or not use an automated exposure notification service.”
[6] Section 5(a)(1) of the Occupational Safety and Health Act of 1970.
[7] See “Pandemic Preparedness in the Workplace and the Americans with Disabilities Act,” U.S. Equal Employment Opportunity Commission (last updated March 21, 2020), available here.
[8] See 42 U.S.C. § 12112 & 29 C.F.R. § 1630.14.
[9] HIPAA’s Privacy Rule applies to disclosures made by employees, volunteers and other members of a covered entity’s and/or business associate’s workforce. A covered entity is a health plan, health care clearinghouse or health care provider who conducts certain health care transactions electronically (e.g., transmitting health care claims to a health plan). “Business associates” are generally individuals or entities that perform functions on behalf of, or provide services to, a covered entity. Business associates also include subcontractors that create, receive, maintain or transmit protected health information (“PHI”) on behalf of another business associate.
[10] HIPAA is carved out of, but not preempted by, the Wicker Bill and Blumenthal Bill. Therefore, entities that are regulated by HIPAA likely would not be regulated by the Wicker Bill and Blumenthal Bill.
[11] The SHIELD Act’s data security requirements may not apply to all employers. For example, fund managers are likely outside such requirements. See “Data Security: Update for Private Fund Managers — NY SHIELD Act,” SRZ Alert, March 18, 2020, available here.
This is a fast-moving topic and the information contained in this Alert is current as of the date it was published.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

What You Need to Know About Cryptocurrency Tax
ARTICLE / CLIENT ALERT
What You Need to Know About Cryptocurrency Tax
June 2020
Read time: 7 min
For many, the world of virtual currency (or cryptocurrency) is complex at best, murky at worst. When it comes to the tax treatment of virtual currency holdings and transactions, the situation can become even less clear.
In this series of must-read articles, we explore many of the need-to-know tax issues that arise from the acquisition, holding and sale of virtual currencies.
- SPECIFIC IDENTIFICATION OF VIRTUAL CURRENCY POSITIONS – The IRS views convertible virtual currency as property, not foreign currency. As such, taxpayers must record and track the tax basis of each unit of virtual currency held in order to property report taxable gain or loss when disposing of a unit or units of virtual currency. This article reviews the IRS’s position with respect to the identification and tax basis of such units.
- THE LEGAL EFFECT OF IRS PRONOUNCEMENTS ON VIRTUAL CURRENCY – Given limited guidance by US tax authorities regarding taxation of virtual currency activities, taxpayers with such holdings may find themselves in uncharted territory as to whether to take positions that are contrary to IRS pronouncements. This article explores relevant notices, rulings and FAQs, and reviews the types of deference that courts tend to put on different types of IRS interpretations and guidance.
- VIRTUAL CURRENCY LOSSES DISALLOWED ON INFREQUENT ACTIVITIES – If a taxpayer’s virtual currency activities are too infrequent to rise to the level of investment activities or do not qualify as trader or dealer activities, losses associated with virtual currency transactions are not deductible. This article explores tax-law issues that arise in the context of “personal use virtual currency” and reminds taxpayers to be aware of both their intent when acquiring or holding virtual currency and the potential tax implications arising from such activities.
- CAN A VIRTUAL CURRENCY POSITION BE TREATED AS A COMMODITY FOR TAX PURPOSES? – Some virtual currency units and positions are treated as commodities by the CFTC and US courts. The IRS has told taxpayers that it views convertible virtual currency as property, not foreign currency, for federal tax purposes. Lacking clear guidance from either the IRS or the Department of the Treasury, this article addresses issues that may help determine whether Internal Revenue Code provisions that apply to commodities might also apply to transactions involving virtual currencies and positions.
- CAN A VIRTUAL CURRENCY POSITION BE TREATED AS A SECURITY FOR TAX PURPOSES? – Some virtual currency units and positions are treated as securities by the SEC and US courts. The IRS, however, has told taxpayers that it views convertible virtual currency as property, not foreign currency, for federal tax purposes. Lacking clear guidance from the IRS or the Department of the Treasury, this article addresses issues that may help determine whether Internal Revenue Code provisions that apply to securities might also apply to transactions involving virtual currencies and positions.
- WHAT IS THE SIGNIFICANCE OF VIRTUAL CURRENCY NOT BEING TAXED AS CURRENCY? – Virtual currencies are not currently accepted as the legal tender or “fiat” currency of any country. In the United States, the IRS has stated its view that convertible virtual currency is property, subject to the general tax rules that apply to property, and is not foreign currency. As such, virtual currency does not qualify for the special tax rules available to foreign currency transactions. This article explores the major consequences of this rule on taxpayers.
- WHEN VIRTUAL CURRENCY POSITIONS ARE SUBJECT TO THE WASH SALES RULE – Under the wash sales rule, taxpayers cannot deduct a loss on the sale of stock or securities if the taxpayer purchases the same or substantially similar assets a short time before or after the sale that triggered the loss. This article examines possible application of the wash sales rule to virtual currencies.
- WHEN VIRTUAL CURRENCY POSITIONS ARE SUBJECT TO THE STRADDLE RULES – Taxpayers who hold virtual currency positions may be subject to the tax straddle rules that require them to defer losses on one offsetting position to the extent of unrecognized gain on other offsetting positions. This article explores guidance (or the lack thereof) relating to actively traded personal property, offsetting positions and other issues as applied to virtual currency holdings.
- SPECIAL TAX RULES APPLY TO BITCOIN FUTURES AND OPTIONS AND MIGHT APPLY TO POSITIONS IN ETHER AND OTHER VIRTUAL CURRENCIES IN THE FUTURE – Special tax rules require taxpayers to treat gains on certain virtual currency positions as taxable even though they still hold their positions. These rules apply to futures and options that qualify as section 1256 contracts, which is potentially relevant to taxpayers buying, selling, and holding Bitcoin futures and options, as well as Ether futures and other virtual currencies. This article reviews a number of issues that arise—or may arise in the future—for taxpayers with virtual currency positions.
- WHEN CAN BITCOIN POSITIONS BE TAXED AS MIXED STRADDLES SUBJECT TO THE SPECIAL MIXED STRADDLE RULES? – Taxpayers who enter into offsetting positions in actively traded personal property where one or more—but not all—of the positions making up a straddle are taxed as section 1256 contracts (while another offsetting position is not a section 1256 contract) are subject to the mixed straddle rules. Potential adverse consequences can be magnified or made more complex by application of these special rules. This article can help taxpayers understand and take action to minimize or avoid these consequences when such positions involve virtual currencies.
- CAN VIRTUAL CURRENCY TRADERS ELECT INTO SPECIAL RULES THAT ALLOW CURRENT DEDUCTIONS FOR TRADING LOSSES? – Traders in virtual currency seeking to deduct trading losses and avoid application of the capital loss limitations would want to elect into the special tax rules found at I.R.C. § 475(f). However, such taxpayers should analyze the definitions of “securities” and “commodities,” determine whether they are eligible for either of the trader elections, and consider the federal and state tax implications of making such an election.
- TAXATION OF VIRTUAL CURRENCY MINING ACTIVITIES – Proof of work (PoW)—one of the consensus methodologies through which blockchain (digital ledger) transactions can be validated—relies on data miners whose mining activities involve solving complex mathematical calculations. This article discusses key tax issues for miners and the IRS’s preliminary views involving taxation of Bitcoin PoW mining activities.
- TAXATION OF VIRTUAL CURRENCY STAKING ACTIVITIES – Stakers—taxpayers involved in proof of stake (PoS) validation of blockchain transactions—are operating in uncharted tax waters. Treasury and the IRS have provided no guidance regarding when or whether staking rewards are included in taxable income. This article reviews various considerations that may help stakers document activities, rewards and expenses that support their federal and state tax positions.
- ARE CRYPTO LOANS TAXED AS LOANS? – Transactions involving the borrowing and lending of units of virtual currency (or crypto loans) are increasing in number and type. Lacking Treasury or IRS guidance with respect to crypto loans, potential tax issues that arise from these transactions must be analyzed and understood in accordance with broad, general tax principles established by case law and based on government guidance developed in other tax areas.

Virtual Currency Losses Disallowed on Infrequent Activities
ARTICLE / CLIENT ALERT
Virtual Currency Losses Disallowed on Infrequent Activities
June 3, 2020
Read time: 4 min
If a taxpayer’s virtual currency activities are too infrequent to rise to the level of investment activities or do not qualify as trader or dealer activities, losses associated with virtual currency transactions are not deductible. This article explores tax-law issues that arise in the context of “personal use virtual currency” and reminds taxpayers to be aware of both their intent when acquiring or holding virtual currency and the potential tax implications arising from such activities.
A taxpayer’s losses on virtual currency transactions are not deductible if the taxpayer’s activities are too infrequent to rise to the level of investment activities and the activities do not qualify as trader or dealer activities. In these situations, the taxpayer’s virtual currency transactions are treated as personal transactions, a hobby or entered into for recreational use (collectively referred to as “personal use virtual currency”). Personal use transactions include buying, selling or otherwise disposing of personal use virtual currency; using personal use virtual currency to buy goods or services; and converting personal use virtual currency into another virtual currency or a fiat currency.
Taxpayer intent when acquiring convertible virtual currency is important in determining whether the virtual currency is a personal asset. Personal use virtual currency is generally taxed as a capital asset, with some important tax differences:
Because of tax law changes in 2017, losses from the sale of personal use virtual currency are not tax deductible (IRS, Topic No. 409 Capital Gains and Losses, last updated Sept. 21, 2017). Gains, however, are taxable as capital gains. This means personal use virtual currency results in taxable capital gains and nondeductible losses.
Also as a result of the 2017 tax law changes, a taxpayer cannot deduct any expenses attributable to personal use virtual currency.
The taxpayer’s standard capital gain rate applies to personal use virtual currency. Because virtual currencies are intangible assets, they are not subject to the maximum capital gains tax rate applicable to tangible assets that are taxed as collectibles (such as coins or artworks) (Topic No. 409).
Personal use virtual currency transactions are reported on IRS Form 8949, Sales and Other Dispositions of Capital Assets.
All gains on personal use virtual currency are taxable. Based on Notice 2014-21, virtual currency is not treated as currency for federal tax purposes. This means that even though I.R.C. §988(e) allows individual taxpayers to exclude up to $200 of gains from personal foreign currency transactions, such a de minimis gain exemption does not apply to personal use virtual currencies.
In summary, all of a taxpayer’s gains on personal use virtual currencies are taxable at the same tax rates as the taxpayer’s other capital assets, although none of the taxpayer’s losses are deductible.
On an ongoing basis, taxpayers should evaluate their purpose in acquiring and holding virtual currency to determine whether their activities remain taxed as personal activities. Given the tax differences between personal assets and other assets, taxpayers should keep accurate records to evaluate whether their activities have changed to warrant a different tax characterization (See IRS Small Business and Self-Employed Tax Center). If virtual currency activities qualify as investor, trader or dealer activities, different tax rules will apply. Taxpayers should also consider potential application of other tax rules that can disallow losses, such as possible application of the wash sales rules, limitations on passive activities, and sales to related persons and entities.

Specific Identification of Virtual Currency Positions
ARTICLE / CLIENT ALERT
Specific Identification of Virtual Currency Positions
June 3, 2020
Read time: 5 min
The IRS views convertible virtual currency as property, not foreign currency. As such, taxpayers must record and track the tax basis of each unit of virtual currency held in order to property report taxable gain or loss when disposing of a unit or units of virtual currency. This article reviews the IRS’s position with respect to the identification and tax basis of such units.
Taxpayers need to record and track the tax basis of each and every unit of virtual currency they hold in their wallet, account or address to properly report taxable gain or loss each time they dispose of a unit or units. In general, the tax basis of property is its cost (expressed in US dollars) paid to acquire the virtual currency, including any commissions, fees and acquisition costs (I.R.C. § 1012(a).). This article addresses specific identification requirements for dispositions of convertible virtual currency. It starts from the US Internal Revenue Service’s (IRS) view that convertible virtual currency is property. For a discussion of the legal authority of IRS Notices and other pronouncements, see McDermott’s article, “The Legal Effect of IRS Pronouncements on Virtual Currency Taxation.”
IRS Notice 2014-21 (2014-16 I.R.B. 938, Q&A 7) and 2019 Frequently Questions (FAQs; IR-2019-167) set out the IRS’s views with respect to certain aspects of the taxation of convertible virtual currency. The IRS takes the position that virtual currency is property—not foreign currency—for federal tax purposes (Notice 2014-21, Q&As 1 and 2). As such, the IRS reasons, each separate coin, token or unit (collectively, unit) of convertible virtual currency has its own tax basis (Q&A 4). In addition, the tax basis of virtual currency received as payment for goods or services is treated as its fair market value as of the date of receipt (Q&A 3). Tax character of gain or loss from disposing of virtual currency turns on whether the virtual currency is an ordinary or capital asset in the taxpayer’s hands (Q&A 7). The IRS treats purchases made with virtual currency as barter exchanges, which means that both the person receiving units and the person spending units have taxable gain or loss (Q&As 1 and 2).
Why Tax Basis Is Important
Although tracking tax basis on a unit-by-unit basis might be burdensome for some taxpayers and some transactions, it provides taxpayers with an opportunity for significant tax benefits. Taxpayers can pick and choose which units they want to sell. They can select those units with the highest tax basis to minimize their current taxation and push gains into future tax years. Or, they can maximize current taxation by selling those units with the lowest tax basis.
Taxpayers who choose not to identify their units are subject to a default tax basis rule, meaning they will be taxed on the sale of their units on a first–in–first–out basis (FIFO; FAQ, 40).
Average Cost Method Not Available
Taxpayers holding multiple units of a given virtual currency often acquire these units at different times and at different prices. If they sell a portion, but not all, of their units at any given time, they might want to use the average cost method to calculate their gains and losses. The average cost method is mandatory for partnership interests, foreign currency that is the taxpayer’s functional currency and certain corporate transactions. It is elective for taxpayers who hold mutual fund shares. The average cost method allows, for example, electing taxpayers to calculate the value of their mutual fund positions on an aggregate basis to determine their profit or loss. Such electing taxpayers can determine their tax basis by taking the average cost of all of the shares they own in a particular fund and multiplying the average cost by the number of fund shares they are selling. The average cost method can be a simple way to handle mutual fund sales for taxpayers who reinvest their mutual fund dividends and regularly add to their mutual fund holdings (I.R.C.§ 1012(c)(1)). But no US Department of the Treasury or IRS authority allows for the use of the average cost method for virtual currency.
Specifically Identifying Virtual Currency
According to the IRS Notice and FAQs, taxpayers have two ways to identify the basis of their specific units. First, taxpayers can document a specific unit’s unique digital identifier—such as a private key, public key or address. Or, they can record all of the transaction information for the units in a single account, wallet or address (FAQ, 36 and 37).
To comply with specific identification, taxpayers must record the following information:
The date and time each unit was acquired
The basis and fair market value of each unit at the time acquired
The date and time each unit was sold, exchanged or otherwise disposed of
The fair market value of each unit when disposed of
The amount of money or the value of property received for each unit (FAQ, 39).
By maintaining this information, taxpayers can dispose of high basis units first, minimizing their current tax and deferring taxable gains. Specific identification allows taxpayer complete flexibility in selecting the units they want to sell. In fact, taxpayers can replicate any of the possible basis tracking methods, changing their selection criteria as their tax objectives change.
* * * *
With the tracking capabilities of blockchain and a reputable technology and data service provider, taxpayers can establish reliable systems to record their transactions and track their costs.